Charles Schwab Investment Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 638,223 shares of REGN stock, worth $671 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
638,223
Previous 620,616 2.84%
Holding current value
$671 Million
Previous $545 Million 12.7%
% of portfolio
0.14%
Previous 0.14%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$902.69 - $993.35 $15.9 Million - $17.5 Million
17,607 Added 2.84%
638,223 $614 Million
Q4 2023

Feb 06, 2024
BUY
$775.18 - $881.7 $17.5 Million - $19.9 Million
22,558 Added 3.77%
620,616 $545 Million
Q3 2023

Nov 08, 2023
SELL
$692.45 - $844.37 $1.37 Million - $1.67 Million
-1,978 Reduced 0.33%
598,058 $492 Million
Q2 2023

Aug 09, 2023
BUY
$700.03 - $830.35 $3.1 Million - $3.68 Million
4,432 Added 0.74%
600,036 $431 Million
Q1 2023

May 11, 2023
BUY
$680.49 - $826.97 $5.89 Million - $7.16 Million
8,661 Added 1.48%
595,604 $489 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $9.84 Million - $10.7 Million
13,940 Added 2.43%
586,943 $423 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $1.46 Million - $1.84 Million
2,541 Added 0.45%
573,003 $395 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $4.57 Million - $6.15 Million
8,326 Added 1.48%
570,462 $337 Million
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $3.48 Million - $4.08 Million
5,842 Added 1.05%
562,136 $393 Million
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $14.5 Million - $18 Million
26,766 Added 5.05%
556,294 $351 Million
Q3 2021

Nov 16, 2021
BUY
$574.03 - $680.96 $14.1 Million - $16.8 Million
24,645 Added 4.88%
529,528 $320 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $2.41 Million - $2.84 Million
5,093 Added 1.02%
504,883 $282 Million
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $7.31 Million - $8.97 Million
-16,359 Reduced 3.17%
499,790 $236 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $2.86 Million - $3.64 Million
5,985 Added 1.17%
516,149 $249 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $21 Million - $25.4 Million
38,641 Added 8.19%
510,164 $286 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $56.4 Million - $73.7 Million
114,426 Added 32.04%
471,523 $294 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $60,848 - $89,491
181 Added 0.05%
357,097 $174 Million
Q4 2019

Feb 07, 2020
SELL
$274.13 - $376.51 $3.5 Million - $4.81 Million
-12,784 Reduced 3.46%
356,916 $134 Million
Q3 2019

Nov 08, 2019
SELL
$273.46 - $318.39 $6.61 Million - $7.69 Million
-24,168 Reduced 6.14%
369,700 $103 Million
Q2 2019

Aug 09, 2019
BUY
$299.6 - $414.82 $7.35 Million - $10.2 Million
24,540 Added 6.64%
393,868 $123 Million
Q1 2019

May 14, 2019
BUY
$372.08 - $439.57 $27 Million - $31.9 Million
72,588 Added 24.46%
369,328 $152 Million
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $3.28 Million - $3.94 Million
9,766 Added 3.4%
296,740 $111 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $180,837 - $210,382
515 Added 0.18%
286,974 $116 Million
Q2 2018

Aug 08, 2018
SELL
$284.6 - $344.99 $3.02 Million - $3.66 Million
-10,618 Reduced 3.57%
286,459 $98.8 Million
Q1 2018

May 07, 2018
BUY
$315.82 - $393.78 $3.95 Million - $4.93 Million
12,510 Added 4.4%
297,077 $102 Million
Q4 2017

Jan 17, 2018
BUY
$358.63 - $469.95 $5.71 Million - $7.48 Million
15,924 Added 5.93%
284,567 $107 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $116 Million - $135 Million
268,643
268,643 $120 Million

Others Institutions Holding REGN

# of Institutions
1,424
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email